Autism And Cbd: What Science Says About Hemp Therapy [FItVIfuYe3z]
#47 Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
In this article, the focus is on CBD, a non-psychoactive compound found in cannabis plants, distinct from THC. The research discussed explores CBD’s potential therapeutic benefits for individuals with autism spectrum disorder (ASD). While more studies are needed to confirm its efficacy and safety, preliminary findings suggest that CBD may help manage symptoms such as anxiety, sleep disturbances, and irritability in some ASD patients. Clinicians should be aware of the growing interest in CBD therapy for their ASD patients and consider discussing it as a potential treatment option, given its minimal side effects compared to traditional medications.
🔬 In the realm of healthcare, growing interest surrounds Cannabidiol (CBD), a non-psychoactive compound from cannabis plants, distinct from THC. Recent research on CBD and Autism suggests potential benefits, particularly in managing symptoms such as anxiety, sleep disturbances, and inflammation. However, it’s crucial to acknowledge the complexity of this area, with limited high-quality evidence and varying results across studies. Confounders like dosage, route of administration, and individual susceptibility can significantly impact outcomes. In clinical practice, healthcare providers should approach CBD as a potential adjunct therapy for autism, but further well-designed studies are needed to confirm its efficacy and safety in this population.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.